FDA Adverse Event Injury Summary report: N

PRECISION®

MDR report key: 3133356 · Received May 29, 2013

Report

Report Number
3006630150-2013-01087
Event Type
Injury
Date Received
May 29, 2013
Date of Event
May 3, 2013
Report Date
May 3, 2013
Manufacturer
BOSTON SCIENTIFIC NEUROMODULATION
Product Code
LGW
PMA / PMN Number
030017
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
FL, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

DEVICE EVALUATION INDICATED THAT THE IPG PASSED THE VISUAL, PERFORMANCE AND PHOTOGRAPHIC IMAGING TESTS PERFORMED. THE POSSIBILITY THAT ELECTRICAL LEAKAGE COULD CAUSE PAIN IN THE PATIENT¿S POCKET SITE WAS INVESTIGATED. CURRENT LEAKAGE TESTS AND RESIDUAL GAS ANALYSIS VERIFIED THAT THERE WAS NO LOSS OF ELECTRIC CURRENT INTO THE SURROUNDING TISSUE AS A RESULT OF FAULTY INSULATION. THE IPG PASSED ALL THE REQUIRED TESTS AND REVEALED NO ANOMALIES. DEVICE EVALUATION INDICATED THAT THE PADDLE LEAD PASSED THE PHOTOGRAPHIC IMAGING TEST PERFORMED. THE PADDLE LEAD WAS CUT. DAMAGE TO THE LEAD WAS A RESULT OF A TYPICAL EXPLANT PROCEDURE, AND IT WAS NOT CONSIDERED A FAILURE.

Additional Manufacturer Narrative · 1

ADDITIONAL SUSPECT MEDICAL DEVICE COMPONENTS INVOLVED IN THE EVENT: MODEL #: SC-8216-70, SERIAL #: (B)(4), DESCRIPTION: ARTISAN SURGICAL LEAD, 70CM.

Description of Event or Problem · 1

A REPORT WAS RECEIVED THAT THE PATIENT HAD PAIN AT THE IPG SITE RELATED TO SITTING ON A BONY PROMINENCE AND CAUSING DISCOMFORT AT THE PATIENT¿S PELVIC AREA. THE PATIENT UNDERWENT EXPLANT PROCEDURE AND WAS DOING WELL POST OPERATIVELY.

Description of Event or Problem · 1

A REPORT WAS RECEIVED THAT THE PATIENT HAD PAIN AT THE IPG SITE RELATED TO SITTING ON A BONY PROMINENCE AND CAUSING DISCOMFORT AT THE PATIENT¿S PELVIC AREA. THE PATIENT UNDERWENT EXPLANT PROCEDURE AND WAS DOING WELL POST OPERATIVELY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
235098 PRECISION® SPINAL CORD STIMULATOR LGW BOSTON SCIENTIFIC NEUROMODULATION SC-1110-02 NA

Patients

Seq Age Sex Outcome Treatment
1 60 YR Required Intervention